Alemtuzumab is a drug used in the treatment of chronic lymphocytic leukemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma under the trade names Campath, ...
Easy to read patient leaflet for alemtuzumab. Includes indications, proper use, special instructions, precautions, and possible side effects.
Campath, alemtuzumab is a major step forward in the treatment of B-cell chronic lymphocytic leukemia (B-CLL).
This page contains brief information about alemtuzumab and a collection of links to more information about the use of this drug, research results, and ongoing ...
Learn about the prescription medication Campath (Alemtuzumab), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling.
The US Food and Drug Administration (FDA) has approved alemtuzumab (Lemtrada, Genzyme, a Sanofi Company) for the treatment of relapsing forms of multiple sclerosis (MS).
Alemtuzumab Definition Alemtuzumab is sold as Campath in the United States. Alemtuzumab is a humanized monoclonal antibody that selectively binds to CD52, a protein ...
Consumer information about the medication ALEMTUZUMAB - INJECTION (Campath), includes side effects, drug interactions, recommended dosages, and storage information.
Alemtuzumab (sold under the brand name Lemtrada, and in the past also known as CAMPATH-1H) is a treatment for relapsing MS. Who can take alemtuzumab?
Professional guide for Alemtuzumab. Includes: pharmacology, pharmacokinetics, contraindications, interactions, adverse reactions and more.